Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking

Current Addiction Reports

Volumn 1, Issue 1, 2014, Pages 53-60

  Allen, Alicia M ^a   Oncken, Cheryl ^b   Hatsukami, Dorothy ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cessation; Gender; Health Effects; Nicotine; Sex Hormones; Smoking; Women

Indexed keywords

EID: 84908604168     PISSN: None     EISSN: 21962952     Source Type: Journal    
DOI: 10.1007/s40429-013-0003-6     Document Type: Review

References (82)

1. CDC. Smoking and tobacco use. Surgeon General’s Reports 2001. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2001/index.htm. Accessed October 10, 2013.
2. CDC. Smoking and tobacco use. Surgeon General’s Reports 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm. Accessed October 10, 2013.
3. CDC. Smoking and tobacco use. 2010 Surgeon General’s Report: How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2010/index.htm. Accessed October 10, 2013.
4. Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133–41. This study provides an updated estimate of the effect of smoking on morbidity and mortality in a sample of over 1.2 million women followed for eight years.
5. Taylor DH, Vasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking for longevity. Am J Public Health. 2002;92(6):990–6.
6. Duckworth AL, Chertok IRA. Review of perinatal partner-focused smoking cessation interventions. MCN. Am J Matern Child Nurs. 37(3):174–81
7. Duaso M, Duncan D. Health impact of smoking and smoking cessation strategies: current evidence. Br J Community Nurs. 2012;17(8):356–63.
8. CDC. Current cigarette smoking among adults - United States 2011. MMWR. 2012;61:889–94.
9. CDC. Current tobacco use among middle and high school students - United States, 2011. MMWR. 2012;61:581–5.
10. Mehta N, Preston S. Continued increases in the relative risk of death from smoking. Am J Public Health. 2012;102(11):2181–6. This study found that despite decline prevalence of smoking, the relative risk of death for current and former smokers continues to rise.
11. Rostron B. Smoking-attributable mortality by cause in the United States: revising the CDC’s data and estimates. Nicotine Tob Res. 2013;15(1):238–46.
12. Hjellvik V, Selmer R, Gjessing HK, Tverdal A, Vollset SE. Body mass index, smoking, and risk of death between 40 and 70 years of age in a Norwegian cohort of 32,727 women and 33,475 men. Eur J Epidemiol. 2013;28(1):35–43.
13. Anderson JC, Moezardalan K, Messina CR, Latreille M, Shaw RD. Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: analysis of exposure and anatomical location in men and women. Dig Dis Sci. 2011;56(12):3616–23.
14. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737–45.
15. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: A prospective cohort study. Br Med J. 2013;1016(March 2011):1–25. This paper identified increased risk of breast cancer among women who have smoked more or for a longer period of time.
16. Collins S, Rollason TP, Young LS, Woodman CBJ. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer. 2010;46(2):405–11.
17. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297–305.
18. Cupisti S, Häberle L, Dittrich R, et al. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertil Steril. 2010;94(2):673–7.
19. Guaderrama MM, Corwin EJ, Kapelewski CH, Klein LC. Sex differences in effects of cigarette smoking and 24-hr abstinence on plasma arginine vasopressin. Addict Behav. 2011;36(11):1106–9.
20. Mieczkowska J, Mosiewicz J, Sak J, et al. Effects of cigarette smoking, metabolic syndrome and dehydroepiandrosterone deficiency on intima-media thickness and endothelial function in hypertensive postmenopausal women. Med Sci Monit. 2012;18(4):CR225–34.
21. Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310(1):94–6. This paper is the first to combine the effect of smoking cessation, weight gain and diabetes on coronary heart disease risk.
22. Korhonen T, Goodwin A, Miesmaa P, Dupuis EA, Kinnunen T. Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Women's Health. 2011;20(7):1051–64. This paper is the first to reveal that exercise during smoking cessation results in an improvement of cardiovascular disease biomarkers.
23. Barzi A, Lenz A, Labonte MJ, Lenz HJ. Molecular Pathways: Estrogen Pathway in Colorectal Cancer. Clin Cancer Res. 2013
24. Benson VS, Green J, Pirie K, Beral V. Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the Million Women Study. Br J Cancer. 2010;102(11):1654–6.
25. Dafopoulos A, Dafopoulos K, Georgoulias P, et al. Smoking and AMH levels in women with normal reproductive history. Arch Gynecol Obstet. 2010;282(2):215–9.
26. Dušková M, Simůnková K, Hill M, et al. Chronic cigarette smoking alters circulating sex hormones and neuroactive steroids in premenopausal women. Physiol Res. 2012;61(1):97–111. This is the first study to examine the effect of smoking on sex hormones by menstrual phase in premenopausal women.
27. Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev. 2013;22(1):58–68.
28. Fréour T, Dessolle L, Lammers J, Lattes S, Barrière P. Comparison of embryo morphokinetics after in vitro fertilization-intracytoplasmic sperm injection in smoking and nonsmoking women. Fertil Steril. 2013;99(7):1944–50.
29. Freour T, Masson D, Dessolle L, et al. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen. Arch Gynecol Obstet. 2012;285(4):1177–82.
30. Plante BJ, Cooper GS, Baird DD, Steiner AZ. The impact of smoking on antimullerian hormone levels in women aged 38-50. Menopause. 2010;17(3):571–6.
31. Waylen AL, Jones GL, Ledger WL. Effect of cigarette smoking upon reproductive hormones in women of reproductive age: a retrospective analysis. Reprod Biomed Online. 2010;20(6):861–5.
32. Brand JS, Chan M-F, Dowsett M, et al. Cigarette smoking and endogenous sex hormones in postmenopausal women. J Clin Endocrinol Metab. 2011;96(10):3184–92.
33. Bjarnason NH, Jorgensen HL, Christiansen C. Acute and long-term estradiol kinetics in smoking postmenopausal women. Climacteric. 2012;15:449–54.
34. Chen Y, Mai X-M. Smoking and asthma in men and women with normal weight, overweight, and obesity. J Asthma. 2011;48(5):490–4.
35. Tähtinen RM, Auvinen A, Cartwright R, Johnson TM, Tammela TLJ, Tikkinen KAO. Smoking and bladder symptoms in women. Obstet Gynecol. 2011;118(3):643–8.
36. Overson E, Allen A, Hertsgaard L, Allen S, Wyman J, Hatsukami D. Severity of incontinence symptoms in smokers and role of tobacco exposure and respiratory symptoms. Available at: http://www.wmhealth.umn.edu/events/research-conference/conference-poster-abstracts/index.htm.
37. Perkins KA. Smoking cessation in women: special considerations. CNS Drugs. 2001;15(5):391–411.
38. Torchalla I, Okoli CTC, Bottorff JL, Qu A, Poole N, Greaves L. Smoking cessation programs targeted to women: a systematic review. Women Health. 2012;52(1):32–54.
39. Hussaini AE, Nicholson LM, Shera D, Stettler N, Kinsman S. Adolescent obesity as a risk factor for high-level nicotine addiction in young women. J Adolesc Health. 2011;49(5):511–7. This is the first paper to identify obesity as a risk factor severe nicotine addiction in adolescents.
40. Jenks RA, Higgs S. Reactivity to smoking- and food-related cues in currently dieting and non-dieting young women smokers. J Psychopharmacol. 2011;25(4):520–9.
41. Kasteridis P, Yen ST. Smoking cessation and body weight: evidence from the Behavioral Risk Factor Surveillance Survey. Health Serv Res. 2012;47(4):1580–602.
42. Kleppinger A, Litt MD, Kenny AM, Oncken CA. Effects of smoking cessation on body composition in postmenopausal women. J Women's Health. 2010;19(9):1651–7.
43. Cropsey KL, McClure LA, Jackson DO, Villalobos GC, Weaver MF, Stitzer ML. The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention. Am J Public Health. 2010;100(8):1442–8.
44. Kimokoti RW, Newby PK, Gona P, et al. Diet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and men. J Nutr. 2010;140:1287–93.
45. Haibach JP, Homish GG, Giovino GA. A longitudinal evaluation of fruit and vegetable consumption and cigarette smoking. Nicotine Tob Res. 2013;15(2):355–63.
46. Bock BC, Fava JL, Gaskins R, et al. Yoga as a complementary treatment for smoking cessation in women. J Women's Health. 2012;21(2):240–8. This pilot study is the first to reveal that yoga may assist with both smoking cessation and improving mood during cessation.
47. Williams DM, Whiteley JA, Dunsiger S, et al. Moderate intensity exercise as an adjunct to standard smoking cessation treatment for women: a pilot study. Psychol Addict Behav. 2010;24(2):349–54.
48. Napolitano MA, Lloyd-Richardson EE, Fava JL, Marcus BH. Targeting body image schema for smoking cessation among college females: rationale, program description, and pilot study results. Behav Modif. 2011;35(4):323–46.
49. King AC, Cao D, O’Malley SS, et al. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol. 2012;32(5):630–6. This study observed a significant sex difference in the effect of naltrexone on smoking cessation and weight gain.
50. Allen AM, Kleppinger A, Lando H, Oncken C. Effect of nicotine patch on energy intake and weight gain in postmenopausal women during smoking cessation. Eat Behav. 2013;14(4):420–3.
51. Schnoll RA, Wileyto EP, Lerman C. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addict Behav. 2012;37(4):565–8.
52. Oncken C, Arias AJ, Feinn R, et al. Topiramate for Smoking Cessation: A Randomized, Placebo-Controlled, Pilot Study. Nicotine Tob Res. 2013
53. Love SJ, Sheffer CE, Bursac Z, Prewitt TE, Krukowski RA, West DS. Offer of a weight management program to overweight and obese weight-concerned smokers improves tobacco dependence treatment outcomes. Am J Addict. 2011;20(1):1–8.
54. Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol. 2010;18(6):451–61.
55. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res. 2006;8(5):627–38.
56. Allen AM, Allen SS, Lunos S, Pomerleau CS. Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addict Behav. 2010;35(6):549–52.
57. Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36(1):123–32.
58. DeVito E, Herman A, Sofuoglu M. Influences of sex and menstrual cycle phase on response to intravenous nicotine. 2013. Available at: http://www.cpdd.vcu.edu/Pages/Meetings/PastMeet.html.
59. Allen SS, Allen AM, Kotlyar M, Lunos S, Al’absi M, Hatsukami D. Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine Tob Res. 2013;15(6):1091–8.
60. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012;20(4):251–7. This study examined several different sex hormone variables and concluded that the best predictors of smoking behavior were the progesterone to estradiol ratio, and the change in estradiol and progesterone over time.
61. Franklin TR, Ehrman R, Lynch KG, et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt). 2008;17(2):287–92.
62. Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadhyaya HP. Menstrual phase effects on smoking cessation: a pilot feasibility study. J Womens Health (Larchmt). 2008;17(2):293–301.
63. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103(5):809–21.
64. Mazure CM, Toll B, McKee SA, Wu R, O’Malley SS. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114(1):68–72.
65. Allen AM. Allopregnanolone during short-term smoking abstinence: Associations with depressive symptoms, smoking-related symptomatology and nicotine response. 2012. Available at: http://conservancy.umn.edu/bitstream/141131/1/Allen_umn_0130E_13289.pdf.
66. Nakajima M, al’Absi M. Predictors of risk for smoking relapse in men and women: a prospective examination. Psychol Addict Behav. 2012;26(3):633–7.
67. Cofta-Woerpel L, McClure JB, Li Y, Urbauer D, Cinciripini PM, Wetter DW. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011;120(3):596–606.
68. Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine Tob Res. 2012;14(12):1418–25.
69. Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012;21(3):210–20.
70. Korhonen T, Koivumaa-Honkanen H, Varjonen J, Broms U, Koskenvuo M, Kaprio J. Cigarette smoking and dimensions of depressive symptoms: longitudinal analysis among Finnish male and female twins. Nicotine Tob Res. 2011;13(4):261–72.
71. Shiffman S, Rathbun SL. Point process analyses of variations in smoking rate by setting, mood, gender, and dependence. Psychol Addict Behav. 2011;25(3):501–10.
72. Von Stumm S, Deary IJ, Kivimäki M, Jokela M, Clark H, Batty GD. Childhood behavior problems and health at midlife: 35-year follow-up of a Scottish birth cohort. J Child Psychol Psychiatry. 2011;52(9):992–1001.
73. Cougle JR, Zvolensky MJ, Hawkins KA. Delineating a relationship between problematic anger and cigarette smoking: a population-based study. Nicotine Tob Res. 2013;15(1):297–301. This paper is the first population-based study that examined the relationship between problematic anger and smoking.
74. Piñeiro B, López-Durán A, Fernández Del Río E, Martínez U, Becoña E. Gender differences in personality patterns and smoking status after a smoking cessation treatment. BMC Public Health. 2013;13:306.
75. Nieva G, Valero S, Bruguera E, et al. The alternative five-factor model of personality, nicotine dependence and relapse after treatment for smoking cessation. Addict Behav. 2011;36(10):965–71.
76. Brook JS, Zhang C, Brook DW, Koppel J, Whiteman M. Psychosocial predictors of nicotine dependence among women during their mid-sixties. Am J Addict. 2012;21(4):302–12.
77. Arbour-Nicitopoulos KP, Faulkner GE, Cohn TA, Selby P. Smoking cessation in women with severe mental illness: exploring the role of exercise as an adjunct treatment. Arch Psychiatr Nurs. 2011;25(1):43–52.
78. Cinciripini PM, Robinson JD, Karam-Hage M, et al. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry. 2013;70(5):522–33.
79. Hertsgaard L, Vogel R, Hatsukami D. Gender differences in cigarettes abstinence rates in a study comparing the use of very low nicotine content cigarettes along or in combination with a 21 mg nicotine patch to the use of the patch alone. 2013. Available at: http://srnt.org/conferences/SRNT_2013_Abstracts_I-Modified.pdf.
80. Cropsey KL, Jackson DO, Hale GJ, Carpenter MJ, Stitzer ML. Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav. 2011;36(1–2):73–8.
81. Wetter DW, McClure JB, Cofta-Woerpel L, et al. A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women. Psychol Addict Behav. 2011;25(2):365–71.
82. Weiss C, Hanebuth D, Coda P, Dratva J, Heintz M, Stutz EZ. Aging images as a motivational trigger for smoking cessation in young women. Int J Environ Res Public Health. 2010;7(9):3499–512.